Display options
Cite
Xu WS, Sun X, Song CG, et al. Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural Regen Res. 2016;11(5):745-51doi: 10.4103/1673-5374.182700.
Xu, W. S., Sun, X., Song, C. G., Mu, X. P., Ma, W. P., Zhang, X. H., & Zhao, C. S. (2016). Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural regeneration research, 11(5), 745-51. https://doi.org/10.4103/1673-5374.182700
Xu, Wang-Shu, et al. "Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia." Neural regeneration research vol. 11,5 (2016): 745-51. doi: https://doi.org/10.4103/1673-5374.182700
Xu WS, Sun X, Song CG, Mu XP, Ma WP, Zhang XH, Zhao CS. Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia. Neural Regen Res. 2016 May;11(5):745-51. doi: 10.4103/1673-5374.182700. PMID: 27335557; PMCID: PMC4904464.
Copy Download .nbib Format: NLM
Share it on

Neural Regen Res. 2016 May;11(5):745-51. doi: 10.4103/1673-5374.182700.

Bumetanide promotes neural precursor cell regeneration and dendritic development in the hippocampal dentate gyrus in the chronic stage of cerebral ischemia.

Neural regeneration research

Wang-Shu Xu, Xuan Sun, Cheng-Guang Song, Xiao-Peng Mu, Wen-Ping Ma, Xing-Hu Zhang, Chuan-Sheng Zhao

Affiliations

  1. Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China; Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  2. Department of Interventional Neuroradiology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.
  3. Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China; Department of Neurology, Benxi Central Hospital of China Medical University, Benxi, Liaoning Province, China.
  4. Department of Neurology, First Affiliated Hospital of China Medical University, Shenyang, Liaoning Province, China.
  5. Department of Medical Genetics, School of Basic Medicine, Peking University, Beijing, China.
  6. Neuroinfection and Neuroimmunology Center, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

PMID: 27335557 PMCID: PMC4904464 DOI: 10.4103/1673-5374.182700

Abstract

Bumetanide has been shown to lessen cerebral edema and reduce the infarct area in the acute stage of cerebral ischemia. Few studies focus on the effects of bumetanide on neuroprotection and neurogenesis in the chronic stage of cerebral ischemia. We established a rat model of cerebral ischemia by injecting endothelin-1 in the left cortical motor area and left corpus striatum. Seven days later, bumetanide 200 µg/kg/day was injected into the lateral ventricle for 21 consecutive days with a mini-osmotic pump. Results demonstrated that the number of neuroblasts cells and the total length of dendrites increased, escape latency reduced, and the number of platform crossings increased in the rat hippocampal dentate gyrus in the chronic stage of cerebral ischemia. These findings suggest that bumetanide promoted neural precursor cell regeneration, dendritic development and the recovery of cognitive function, and protected brain tissue in the chronic stage of ischemia.

Keywords: Na+-K+-2Cl- cotransporter 1; bumetanide; cerebral ischemia; cognitive function; dendritic development; hippocampal dentate gyrus; nerve regeneration; neural precursor cells; neural regeneration; neurogenesis

References

  1. Proc Natl Acad Sci U S A. 2004 Oct 5;101(40):14515-20 - PubMed
  2. Neuroscience. 2015 Feb 12;286:203-15 - PubMed
  3. Stroke. 2007 Oct;38(10):2833-40 - PubMed
  4. Pediatrics. 1997 Dec;100(6):1004-14 - PubMed
  5. Cell. 2008 Feb 22;132(4):645-60 - PubMed
  6. J Neurochem. 2010 Jul;114(2):520-9 - PubMed
  7. J Cereb Blood Flow Metab. 2002 Mar;22(3):299-307 - PubMed
  8. Trends Neurosci. 2007 Jan;30(1):1-8 - PubMed
  9. Neurosci Lett. 2011 Jan 13;488(1):70-5 - PubMed
  10. J Neurosci. 2012 Feb 1;32(5):1757-70 - PubMed
  11. Stroke. 2010 Mar;41(3):e151-9 - PubMed
  12. J Neurosurg. 2004 Nov;101(5):799-805 - PubMed
  13. Nat Rev Neurosci. 2002 Sep;3(9):715-27 - PubMed
  14. J Neurosci. 2002 Jun 1;22(11):4412-7 - PubMed
  15. J Neurophysiol. 2003 Mar;89(3):1353-62 - PubMed
  16. Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4710-5 - PubMed
  17. J Mol Endocrinol. 2007 Mar;38(3):377-82 - PubMed
  18. Exp Neurol. 2010 Mar;222(1):13-24 - PubMed
  19. Neurol Res. 2007 Jun;29(4):404-9 - PubMed
  20. Int J Clin Exp Pathol. 2014 Mar 15;7(4):1487-94 - PubMed
  21. Neuropharmacology. 2008 Sep;55(3):345-52 - PubMed
  22. Nat Med. 2002 Sep;8(9):963-70 - PubMed
  23. J Neurosci. 1997 Nov 1;17(21):8363-75 - PubMed
  24. J Neurosci. 2008 Nov 12;28(46):11785-91 - PubMed
  25. Neurosurg Focus. 2008 Sep;25(3):E22 - PubMed
  26. Stroke. 2011 Jun;42(6):1757-63 - PubMed
  27. Neuron. 2009 Mar 26;61(6):820-38 - PubMed
  28. Neuroscientist. 2008 Oct;14(5):446-58 - PubMed
  29. Stroke. 1998 Mar;29(3):705-18 - PubMed
  30. Stem Cells. 2006 Mar;24(3):739-47 - PubMed
  31. CNS Neurosci Ther. 2013 Mar;19(3):194-6 - PubMed
  32. Nat Rev Neurosci. 2002 Sep;3(9):728-39 - PubMed
  33. Adv Exp Med Biol. 2004;559:67-75 - PubMed
  34. J Neurosci. 2006 Dec 13;26(50):13007-16 - PubMed
  35. Trends Cogn Sci. 1999 May;3(5):186-192 - PubMed
  36. Pediatr Neurol. 2009 Sep;41(3):171-8 - PubMed
  37. Eur J Neurosci. 2005 Oct;22(8):1916-27 - PubMed

Publication Types